Skip to main content
SpringerLink
Log in

Malignancy and Thrombosis

  • Chapter
Recent Advances in Thrombosis and Hemostasis 2008

  • 1348 Accesses

Abstract

The association between cancer and an increased incidence of venous thromboembolism (VTE; Trousseau syndrome) is well characterized. This chapter reviews the pertinent literature related to VTE in patients with malignancy and the impact and scope of cancer-associated thrombosis, possible risk factors, etiology, pathogenesis, current practice patterns, and future directions.

The following members and their institutions participated in this review article: M Ikeda, Department of Surgery, Graduate School of Medicine, Osaka University, Japan; N Yamada, Department of Cardiology, Mie University Graduate School of Medicine, Japan; K Sueishi (a director), Division of Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Sciences, Kyushu University, Japan; K Susuki (a chair), Department of Molecular Pathobiology, Mie University Graduate School of Medicine, Japan, who belong to Scientific Promotion Committee (SPC) of The Japanese Society on Thrombosis and Hemostasis (JSTH).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clagett GP, Anderson FA Jr, Heit J (1995) Prevention of venous thromboembolism. Chest 108:312S–334S

    Article  PubMed  CAS  Google Scholar 

  2. Kroegel C, Reissig A (2003) Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 70:7–30

    Article  PubMed  Google Scholar 

  3. Sakon M, Kakkar AK, Ikeda M, et al (2004) Current status of pulmonary embolism in general surgery in Japan. Surg Today 34:805–810

    Article  PubMed  Google Scholar 

  4. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389

    Article  PubMed  CAS  Google Scholar 

  5. Kasper W, Konstantinides S, Geibel A (1997) Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30:1165–1171

    Article  PubMed  CAS  Google Scholar 

  6. Cohen AT, Alikhan R, Arcelus JI, et al (2005) Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 94:750–759

    PubMed  Google Scholar 

  7. Sorensen HT, Mellemkjaer L, Olsen JH, et al (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850

    Article  PubMed  CAS  Google Scholar 

  8. Linenberger ML (2006) Catheter-related thrombosis: risks, diagnosis, and management. J Natl Compr Canc Netw 4:889–901

    PubMed  Google Scholar 

  9. Prandoni P (2005) Venous thromboembolism risk and management in women with cancer and thrombophilia. Gend Med 2:S28–S34

    Article  PubMed  Google Scholar 

  10. Pruemer J (2005) Prevalence, causes, and impact of cancer-associated thrombosis. Am J Health Syst Pharm 62:S4–S6

    PubMed  CAS  Google Scholar 

  11. Gerber DE, Grossman SA, Streiff MB (2006) Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol 24:1310–1318

    Article  PubMed  CAS  Google Scholar 

  12. Drake TA, Cheng J, Chang A, et al (1993) Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142:1458–1470

    PubMed  CAS  Google Scholar 

  13. Winter PC (2006) The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology. Hematol Oncol 24:126–133

    Article  PubMed  CAS  Google Scholar 

  14. PIOPED Investigators (1990) Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism (PIOPED). JAMA 263:2753–2759

    Article  Google Scholar 

  15. Kearon C (2001) Epidemiology of venous thromboembolism. Semin Vasc Med 1:7–26

    Article  PubMed  CAS  Google Scholar 

  16. Miyata T, Kimura R, Kokubo Y, et al (2006) Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol 83:217–223

    Article  PubMed  CAS  Google Scholar 

  17. Mizukami K, Nakabayashi T, Naitoh S, et al (2006) One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis. Am J Hematol 81:787–797

    Article  PubMed  CAS  Google Scholar 

  18. Trousseau A (1865) Phlegmasia alba dolens. Clinique Médicale de l’Hôtel-Dieu de Paris, the New Sydenham Society, London 3:94–111

    Google Scholar 

  19. Bergqvist D (2007) Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis. J Surg Oncol 95:167–174

    Article  PubMed  Google Scholar 

  20. Sampson MT, Kakkar AK (2002) Coagulation proteases and human cancer. Biochem Soc Trans 30:201–207

    Article  PubMed  CAS  Google Scholar 

  21. Kazama Y, Hamamoto T, Foster DC, et al (1995) Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 270: 66–72

    Article  PubMed  CAS  Google Scholar 

  22. De Cicco M (2004) The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 50:187–196

    Article  PubMed  Google Scholar 

  23. Koyama T, Nishida K, Ohdama S, et al (1994) Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 87:343–347

    Article  PubMed  CAS  Google Scholar 

  24. Giesen PL, Rauch U, Bohrmann B, et al (1999) Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 96:2311–2315

    Article  PubMed  CAS  Google Scholar 

  25. Bogdanov VY, Balasubramanian V, Hathcock J, et al (2003) Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9:458–462

    Article  PubMed  CAS  Google Scholar 

  26. Uno K, Homma S, Satoh T, et al (2007) Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96:290–295

    Article  PubMed  CAS  Google Scholar 

  27. Guba M, Yezhelyev M, Eichhorn ME, et al (2005) Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood 105:4463–4469

    Article  PubMed  CAS  Google Scholar 

  28. Wang X, Wang E, Kavanagh JJ, et al (2005) Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 3:25

    Article  PubMed  CAS  Google Scholar 

  29. Stahli BE, Camici GG, Steffel J, et al (2006) Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res 99:149–155

    Article  PubMed  CAS  Google Scholar 

  30. Shen BQ, Lee DY, Cortopassi KM, et al (2001) Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells. J Biol Chem 276:5281–5286

    Article  PubMed  CAS  Google Scholar 

  31. Esmon CT (2004) The impact of the inflammatory response on coagulation. Thromb Res 114:321–327

    Article  PubMed  CAS  Google Scholar 

  32. Cao R, Bjorndahl MA, Religa P, et al (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333–345

    Article  PubMed  CAS  Google Scholar 

  33. Rickles FR, Levine M, Edwards RL (1992) Hemostatic alterations in cancer patients. Cancer Metastasis Rev 11:237–248

    Article  PubMed  CAS  Google Scholar 

  34. Osterud B (1998) Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis 9(suppl 1):S9–S14

    PubMed  CAS  Google Scholar 

  35. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264

    Article  PubMed  CAS  Google Scholar 

  36. Rong Y, Post DE, Pieper RO, et al (2005) PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 65:1406–1413

    Article  PubMed  CAS  Google Scholar 

  37. Nguyen QD, De Wever O, Bruyneel E, et al (2005) Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment. Oncogene 24:8240–8251

    Article  PubMed  CAS  Google Scholar 

  38. Fan Y, Zhang W, Mulholland M (2005) Thrombin and PAR-l-AP increase proinflammatory cytokine expression in C6 cells. J Surg Res 129:196–201

    Article  PubMed  CAS  Google Scholar 

  39. Nierodzik ML, Karpatkin S (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10:355–362

    Article  PubMed  CAS  Google Scholar 

  40. Mohle R, Green D, Moore MA, et al (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 94:663–668

    Article  PubMed  CAS  Google Scholar 

  41. Lopez JA, Kearon C, Lee AY (2004) Deep venous thrombosis. Hematology (Am Soc Hematol Educ Program) 439–456

    Google Scholar 

  42. Chen M, Geng JG (2006) P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 54:75–84

    Article  CAS  Google Scholar 

  43. Gordon SG, Mielicki WP (1997) Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul Fibrinolysis 8:73–86

    Article  PubMed  CAS  Google Scholar 

  44. Heit JA (2005) Cancer and venous thromboembolism: scope of the problem. Cancer Control 12(suppl 1):5–10

    PubMed  Google Scholar 

  45. Szajda SD, Jozwik M, Jozwik M, et al (2004) Cancer procoagulant activity in serum and neoplastic tissue in cases of cervical and uterine carcinoma. Ginekol Pol 75:705–712

    PubMed  Google Scholar 

  46. Chen CH, Su KY, Tao MH, et al (2006) Decreased expressions of hepsin in human hepatocellular carcinomas. Liver Int 26:774–780

    Article  PubMed  CAS  Google Scholar 

  47. Kyrle PA, Minar E, Bialonczyk C, et al (2004) The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350:2558–2563

    Article  PubMed  CAS  Google Scholar 

  48. Cunningham MS, White B, O’Donnell J (2006) Prevention and management of venous thromboembolism in people with cancer: a review of the evidence. Clin Oncol (R Coll Radiol) 18:145–151

    CAS  Google Scholar 

  49. Levitan N, Dowlati A, Remick SC, et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using Medicare claims data. Medicine (Baltimore) 78:285–291

    Article  PubMed  CAS  Google Scholar 

  50. Tateo S, Mereu L, Salamano S, et al (2005) Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 99:119–125

    Article  PubMed  CAS  Google Scholar 

  51. Joung S, Robinson B (2002) Venous thromboembolism in cancer patients in Christ-church, 1995–1999. N Z Med J 115:257–260

    PubMed  Google Scholar 

  52. Haddad TC, Greeno EW (2006) Chemotherapy-induced thrombosis. Thromb Res 118:555–568

    Article  PubMed  CAS  Google Scholar 

  53. Nadir Y, Hoffman R, Brenner B (2004) Drug-related thrombosis in hematologic malignancies. Rev Clin Exp Hematol 8:E4

    PubMed  Google Scholar 

  54. Kuenen BC, Levi M, Meijers JC, et al (2003) Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416. J Clin Oncol 21:2192–2198

    Article  PubMed  CAS  Google Scholar 

  55. Behrendt CE, Ruiz RB (2003) Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy. Thromb Haemost 90:734–737

    PubMed  CAS  Google Scholar 

  56. Zangari M, Anaissie E, Barlogie B, et al (2001) Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 98:1614–1615

    Article  PubMed  CAS  Google Scholar 

  57. Desai AA, Vogelzang NJ, Rini BI, et al (2002) A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma. Cancer 95:1629–1636

    Article  PubMed  CAS  Google Scholar 

  58. Deitcher SR, Gomes MP (2004) The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review. Cancer 101:439–449

    Article  PubMed  Google Scholar 

  59. Bohlius J, Wilson J, Seidenfeld J, et al (2006) Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98:708–714

    Article  PubMed  CAS  Google Scholar 

  60. Negus JJ, Gardner JJ, Tann O, et al (2006) Thromboprophylaxis in major abdominal surgery for cancer. Eur J Surg Oncol 32:911–916

    Article  PubMed  CAS  Google Scholar 

  61. Cornwell EE 3rd, Chang D, Velmahos G (2002) Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis. Am Surg 68:470–473

    PubMed  Google Scholar 

  62. Agnelli G, Bergqvist D, Cohen AT, et al (2005) Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 92:1212–1220

    Article  PubMed  CAS  Google Scholar 

  63. Geerts WH, Pineo GF, Heit JA, et al (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:338S–400S

    Article  PubMed  CAS  Google Scholar 

  64. Streiff MB (2006) Long-term therapy of venous thromboembolism in cancer patients. J Natl Compr Canc Netw 4:903–910

    PubMed  CAS  Google Scholar 

  65. Bates SM, Ginsberg JS (2004) Clinical practice: treatment of deep-vein thrombosis. N Engl J Med 351:268–277

    Article  PubMed  CAS  Google Scholar 

  66. Segal JB, Streiff MB, Hoffman LV, et al (2007) Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 146:211–222

    PubMed  Google Scholar 

  67. Kai R, Imamura H, Kumazaki S, et al (2006) Temporary inferior vena cava filter for deep vein thrombosis and acute pulmonary thromboembolism: effectiveness and indication. Heart Vessels 21:221–225

    Article  PubMed  Google Scholar 

  68. Heres EK, Speight K, Benckart D (2001) The clinical onset of heparin is rapid. Anesth Analg 92:1391–1395

    Article  PubMed  CAS  Google Scholar 

  69. Falanga A, Zacharski L (2005) Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol 16:696–701

    Article  PubMed  CAS  Google Scholar 

  70. Levy JH, Hursting MJ (2007) Heparin-induced thrombocytopenia, a prothrombotic disease. Hematol Oncol Clin North Am 21:65–88

    Article  PubMed  Google Scholar 

  71. Cines DB, Rauova L, Arepally G, et al (2007) Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. J Clin Apher 22:31–36

    Article  PubMed  Google Scholar 

  72. Horton J (2005) Venous thrombotic events in cancer: the bottom line. Cancer Control 12:31–37

    PubMed  Google Scholar 

  73. Hull RD, Raskob GE, Rosenbloom D, et al (1997) Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin: an economic perspective. Arch Intern Med 157:289–294

    Article  PubMed  CAS  Google Scholar 

  74. Lecumberri R, Paramo JA, Rocha E (2005) Anticoagulant treatment and survival in cancer patients: the evidence from clinical studies. Haematologica 90:1258–1266

    PubMed  CAS  Google Scholar 

  75. Kakkar A (2005) Low-molecular-weight heparin and survival in patients with malignant disease. Cancer Control 12:22–30

    PubMed  Google Scholar 

  76. Mousa SA, Mohamed S (2004) Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor. Thromb Haemost 92:627–633

    PubMed  CAS  Google Scholar 

  77. Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897–902

    PubMed  CAS  Google Scholar 

  78. Holbrook AM, Pereira JA, Labiris R (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095–1106

    Article  PubMed  CAS  Google Scholar 

  79. Piazza G, Goldhaber SZ (2006) Acute pulmonary embolism. II. Treatment and prophylaxis. Circulation 114:e42–e47

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan

    Hiroshi Kobayashi, Ryuji Kawaguchi, Yoriko Tsuji, Yoshihiko Yamada, Mariko Sakata, Seiji Kanayama, Shoji Haruta & Hidekazu Oi

Authors
  1. Hiroshi Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryuji Kawaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoriko Tsuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshihiko Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mariko Sakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seiji Kanayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shoji Haruta
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hidekazu Oi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Kenzo Tanaka M.D., Ph.D. (Professor Emeritus) (Professor Emeritus)

  2. Department of Biochemistry, University of Washington, J317 Health Science Center, Box 357350, Seattle, WA, 98195, USA

    Earl W. Davie Ph.D. (Professor) (Professor)

  3. School of Medicine, Internal Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Yasuo Ikeda M.D., Ph.D. (Professor) (Professor)

  4. Department of Biology, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581, Japan

    Sadaaki Iwanaga Ph.D. (Professor Emeritus) (Professor Emeritus)

  5. Department of Medicine, Nagoya University, 26 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan

    Hidehiko Saito M.D., Ph.D. (Professor Emeritus) (Professor Emeritus)

  6. Pathophysiological and Experimental Division, Department of Pathology, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Katsuo Sueishi M.D., Ph.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer

About this chapter

Cite this chapter

Kobayashi, H. et al. (2008). Malignancy and Thrombosis. In: Tanaka, K., Davie, E.W., Ikeda, Y., Iwanaga, S., Saito, H., Sueishi, K. (eds) Recent Advances in Thrombosis and Hemostasis 2008. Springer, Tokyo. https://doi.org/10.1007/978-4-431-78847-8_36

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-78847-8_36

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-78846-1

  • Online ISBN: 978-4-431-78847-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation